Document is current
Any future updates will be listed below
-
Authors
Cheng, Ivy https://orcid.org/0000-0001-7740-9558
Rosychuk, Rhonda J.
Yeom, David Seonguk
Jewett, Ray L.
Bielska, Iwona A.
Hayward, Jake
Khangura, Jaspreet
Mohindra, Rohit
Landes, Megan
Hau, Jeffrey P.
Righolt, Christiaan H.
Leeies, Murdoch
Grant, Jennifer
Brooks, Steven C.
Hohl, Corinne M.
,
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (447679, 464947, 466880)
Ontario Ministry of Colleges and Universities (C-655-2129)
Saskatchewan Health Research Foundation (5357)
Genome British Columbia (COV024, VAC007)
Fondation du CHU de Québec (Octroi No. 4007)
Public Health Agency of Canada/COVID-19 Immunity Task Force (2122-HQ-00054)
- License Information
-
More Information
Article History
Received: 11 December 2023
Accepted: 9 October 2024
First Online: 30 December 2024
Declarations
:
: The University of BC Clinical Research Ethics Board reviewed and approved the study protocol (H20-01015) with a waiver for informed consent, allowing us to capture a complete sample.
: Not applicable.
: Not applicable.
: Righolt has received research funding from Pfizer for an unrelated study. Hohl received salary support through a Health Research BC Health Professional Investigator Award during the study period. Authors otherwise declare no competing interests.
